{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fneurologypodcast.simplecast.com%2Fepisodes%2Fnovel-agents-c67NAb5p","width":444,"version":"1.0","type":"rich","title":"Keeping Up With the Treatment Landscape for MDD","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/3c5d7c90-0775-4a1f-a082-fd9be5194781/psych-summit-mdd-prp6130-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/d8aa8c76-532e-4f31-9560-6fee500bed9a\" height=\"200\" width=\"100%\" title=\"Keeping Up With the Treatment Landscape for MDD\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen as Clinical Care Options talks with Dr Anita Clayton about advances in treatment options for major depression, with a focus on modulators of glutamate and GABA."}